Lv4
540 积分 2025-02-16 加入
Renin-angiotensin-aldosterone system inhibitor use improves clinical outcomes in patients with metabolic dysfunction–associated steatotic liver diseases: Target trial emulation using real-world data
3天前
已完结
Angiotensin‐converting enzyme inhibitors prevent liver‐related events in nonalcoholic fatty liver disease
3天前
已完结
Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II
4天前
已完结
The expression of AT1 receptor on hepatic stellate cells in rat fibrosis induced by CCl4
6天前
已关闭
Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats
6天前
已完结
Angiotensin‐(1‐7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism
13天前
已完结
The ACE2/Ang-(1–7)/Mas axis can inhibit hepatic insulin resistance
13天前
已完结
Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats
13天前
已完结
Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis
13天前
已完结
Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model
13天前
已完结
皖公网安备34019202002308
